206 related articles for article (PubMed ID: 25320748)
1. Kinetics of oral colonization by Candida spp. during topical corticotherapy for oral lichen planus.
Pereira Tdos S; Silva Alves Jde F; Gomes CC; Rocha do Nascimento A; Stoianoff MA; Gomez RS
J Oral Pathol Med; 2014 Sep; 43(8):570-5. PubMed ID: 25320748
[TBL] [Abstract][Full Text] [Related]
2. Candida albicans and Candida tropicalis in oral candidosis: quantitative analysis, exoenzyme activity, and antifungal drug sensitivity.
da Costa KR; Ferreira JC; Komesu MC; Candido RC
Mycopathologia; 2009 Feb; 167(2):73-9. PubMed ID: 18787978
[TBL] [Abstract][Full Text] [Related]
3. Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis.
Godoy JS; de Souza Bonfim-Mendonça P; Nakamura SS; Yamada SS; Shinobu-Mesquita C; Pieralisi N; Fiorini A; Svidzinski TI
J Oral Pathol Med; 2013 Mar; 42(3):229-34. PubMed ID: 22978344
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and antifungal susceptibility of Candida species in a tertiary care hospital in Islamabad, Pakistan.
Tasneem U; Siddiqui MT; Faryal R; Shah AA
J Pak Med Assoc; 2017 Jul; 67(7):986-991. PubMed ID: 28770873
[TBL] [Abstract][Full Text] [Related]
6. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
Skrodeniene E; Dambrauskiene A; Vitkauskiene A
Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyurea therapy in sickle cell anemia patients aids to maintain oral fungal colonization balance.
Salvia AC; Figueiredo MS; Braga JA; Pereira DF; Brighenti FL; Koga-Ito CY
J Oral Pathol Med; 2013 Aug; 42(7):570-5. PubMed ID: 23278631
[TBL] [Abstract][Full Text] [Related]
8. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons.
Sánchez-Vargas LO; Ortiz-López NG; Villar M; Moragues MD; Aguirre JM; Cashat-Cruz M; Lopez-Ribot JL; Gaitán-Cepeda LA; Quindós G
Rev Iberoam Micol; 2005 Jun; 22(2):83-92. PubMed ID: 16107165
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic variability and therapeutic implications of Candida species in patients with oral lichen planus.
Arora S; Verma M; Gupta SR; Urs AB; Dhakad MS; Kaur R
Biotech Histochem; 2016; 91(4):237-41. PubMed ID: 26984382
[TBL] [Abstract][Full Text] [Related]
10. Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
Samra Z; Yardeni M; Peled N; Bishara J
Eur J Clin Microbiol Infect Dis; 2005 Sep; 24(9):592-5. PubMed ID: 16172856
[TBL] [Abstract][Full Text] [Related]
11. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
12. The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran.
Kooshki P; Rezaei-Matehkolaei A; Mahmoudabadi AZ
J Mycol Med; 2018 Jun; 28(2):340-344. PubMed ID: 29530715
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of yeast other than Candida albicans in denture wearers.
Cavaleiro I; Proença L; Félix S; Salema-Oom M
J Prosthodont; 2013 Jul; 22(5):351-7. PubMed ID: 23289581
[TBL] [Abstract][Full Text] [Related]
14. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
[TBL] [Abstract][Full Text] [Related]
15. Oropharyngeal candidiasis in head and neck cancer patients in Iran: Species identification, antifungal susceptibility and pathogenic characterization.
Jahanshiri Z; Manifar S; Moosa H; Asghari-Paskiabi F; Mahmoodzadeh H; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
J Mycol Med; 2018 Jun; 28(2):361-366. PubMed ID: 29602636
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan.
Yang YL; Cheng HH; Ho YA; Hsiao CF; Lo HJ
J Microbiol Immunol Infect; 2003 Sep; 36(3):187-91. PubMed ID: 14582563
[TBL] [Abstract][Full Text] [Related]
17. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
18. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
Jiang L; Yong X; Li R; Peng Y; Liu W; Qin Q; Zhang L; Liu Z; Liang H; Tao R
J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of Mixed- Candida Species Biofilms in Response to Antifungals.
Vipulanandan G; Herrera M; Wiederhold NP; Li X; Mintz J; Wickes BL; Kadosh D
J Dent Res; 2018 Jan; 97(1):91-98. PubMed ID: 28850289
[TBL] [Abstract][Full Text] [Related]
20. Isolation, speciation and antifungal susceptibility testing of Candida isolates from various clinical specimens at a tertiary care hospital, Nepal.
Khadka S; Sherchand JB; Pokhrel BM; Parajuli K; Mishra SK; Sharma S; Shah N; Kattel HP; Dhital S; Khatiwada S; Parajuli N; Pradhan M; Rijal BP
BMC Res Notes; 2017 Jun; 10(1):218. PubMed ID: 28646915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
